The WHO-HAEM4R entity of high-grade B-cell lymphoma with dual rearrangements of MYC and BCL2 and/or BCL6 has been conceptually reframed and reassigned. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.